Research-based pharmaceutical manufacturers need to speed the drug development process and bring new therapies to market. Every day of delay prevents patients from receiving the latest treatment and costs industry millions. Here's a few facts:

It costs, on average, $500 million to bring a drug to market.

Research delays cost industry $1.4 million a day.

Fast development = lower costs and higher market share.

Fast development = lower consumer costs.

New technology and global needs increase the need for clinical testing.

The rate of clinical trials has doubled since 1980.

The number of patients in clinical trials has tripled.

Research-based pharmaceutical firms will spend over $24 billion on research and development a year. The amount is increasing at a +14% rate.

$8 billion (1/3) of this figure is devoted to new drugs in clinical trials.

Independent research sites currently account for 40% of clinical trials.